These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

777 related items for PubMed ID: 19778942

  • 1. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice.
    Muñoz-García B, Moreno JA, López-Franco O, Sanz AB, Martín-Ventura JL, Blanco J, Jakubowski A, Burkly LC, Ortiz A, Egido J, Blanco-Colio LM.
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2061-8. PubMed ID: 19778942
    [Abstract] [Full Text] [Related]

  • 2. Fn14-Fc fusion protein regulates atherosclerosis in ApoE-/- mice and inhibits macrophage lipid uptake in vitro.
    Schapira K, Burkly LC, Zheng TS, Wu P, Groeneweg M, Rousch M, Kockx MM, Daemen MJ, Heeneman S.
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2021-7. PubMed ID: 19762780
    [Abstract] [Full Text] [Related]

  • 3. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes.
    Moreno JA, Sastre C, Madrigal-Matute J, Muñoz-García B, Ortega L, Burkly LC, Egido J, Martín-Ventura JL, Blanco-Colio LM.
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):612-20. PubMed ID: 23288170
    [Abstract] [Full Text] [Related]

  • 4. Considering TWEAK as a target for therapy in renal and vascular injury.
    Ortiz A, Sanz AB, Muñoz García B, Moreno JA, Sánchez Niño MD, Martín-Ventura JL, Egido J, Blanco-Colio LM.
    Cytokine Growth Factor Rev; 2009 Jun; 20(3):251-8. PubMed ID: 19482507
    [Abstract] [Full Text] [Related]

  • 5. TWEAK-Fn14 interaction enhances plasminogen activator inhibitor 1 and tissue factor expression in atherosclerotic plaques and in cultured vascular smooth muscle cells.
    Muñoz-García B, Madrigal-Matute J, Moreno JA, Martin-Ventura JL, López-Franco O, Sastre C, Ortega L, Burkly LC, Egido J, Blanco-Colio LM.
    Cardiovasc Res; 2011 Jan 01; 89(1):225-33. PubMed ID: 20810696
    [Abstract] [Full Text] [Related]

  • 6. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis.
    Madrigal-Matute J, López-Franco O, Blanco-Colio LM, Muñoz-García B, Ramos-Mozo P, Ortega L, Egido J, Martín-Ventura JL.
    Cardiovasc Res; 2010 May 01; 86(2):330-7. PubMed ID: 20154064
    [Abstract] [Full Text] [Related]

  • 7. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
    Dohi T, Borodovsky A, Wu P, Shearstone JR, Kawashima R, Runkel L, Rajman L, Dong X, Scott ML, Michaelson JS, Jakubowski A, Burkly LC.
    Gastroenterology; 2009 Mar 01; 136(3):912-23. PubMed ID: 19109961
    [Abstract] [Full Text] [Related]

  • 8. [Atorvastatin inhibits the atherosclerotic lesion induced by tumor necrosis factor-like weak inducer of apoptosis in apolipoprotein E deficient mice].
    Fernández-Laso V, Sastre C, Egido J, Martín-Ventura JL, Blanco-Colio LM.
    Clin Investig Arterioscler; 2015 Mar 01; 27(1):17-25. PubMed ID: 25027757
    [Abstract] [Full Text] [Related]

  • 9. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
    Ando T, Ichikawa J, Wako M, Hatsushika K, Watanabe Y, Sakuma M, Tasaka K, Ogawa H, Hamada Y, Yagita H, Nakao A.
    Arthritis Res Ther; 2006 Mar 01; 8(5):R146. PubMed ID: 16945157
    [Abstract] [Full Text] [Related]

  • 10. Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts.
    Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T.
    Clin Exp Immunol; 2006 Dec 01; 146(3):540-9. PubMed ID: 17100776
    [Abstract] [Full Text] [Related]

  • 11. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
    Oumouna-Benachour K, Hans CP, Suzuki Y, Naura A, Datta R, Belmadani S, Fallon K, Woods C, Boulares AH.
    Circulation; 2007 May 08; 115(18):2442-50. PubMed ID: 17438151
    [Abstract] [Full Text] [Related]

  • 12. Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice.
    Hernández-Vargas P, Ortiz-Muñoz G, López-Franco O, Suzuki Y, Gallego-Delgado J, Sanjuán G, Lázaro A, López-Parra V, Ortega L, Egido J, Gómez-Guerrero C.
    Circ Res; 2006 Nov 24; 99(11):1188-96. PubMed ID: 17053192
    [Abstract] [Full Text] [Related]

  • 13. CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice.
    Jeon HJ, Choi JH, Jung IH, Park JG, Lee MR, Lee MN, Kim B, Yoo JY, Jeong SJ, Kim DY, Park JE, Park HY, Kwack K, Choi BK, Kwon BS, Oh GT.
    Circulation; 2010 Mar 09; 121(9):1124-33. PubMed ID: 20176988
    [Abstract] [Full Text] [Related]

  • 14. Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.
    Schneider JG, Zhu Y, Coleman T, Semenkovich CF.
    Arterioscler Thromb Vasc Biol; 2007 Dec 09; 27(12):2699-706. PubMed ID: 17951320
    [Abstract] [Full Text] [Related]

  • 15. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P.
    Arterioscler Thromb Vasc Biol; 2007 Dec 09; 27(12):2684-90. PubMed ID: 17916769
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice.
    Erbel C, Chen L, Bea F, Wangler S, Celik S, Lasitschka F, Wang Y, Böckler D, Katus HA, Dengler TJ.
    J Immunol; 2009 Dec 15; 183(12):8167-75. PubMed ID: 20007582
    [Abstract] [Full Text] [Related]

  • 17. Molecular mechanisms of felodipine suppressing atherosclerosis in high-cholesterol-diet apolipoprotein E-knockout mice.
    Yao R, Cheng X, Liao YH, Chen Y, Xie JJ, Yu X, Ding YJ, Tang TT.
    J Cardiovasc Pharmacol; 2008 Feb 15; 51(2):188-95. PubMed ID: 18287887
    [Abstract] [Full Text] [Related]

  • 18. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N, D'Orleans-Juste P, Kiss RS, You Z, Genest J, Al-Ramli W, Qureshi ST, Gramolini A, Behm D, Ohlstein EH, Harrison SM, Douglas SA, Giaid A.
    Circ Res; 2009 Sep 25; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [Abstract] [Full Text] [Related]

  • 19. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.
    Chorianopoulos E, Heger T, Lutz M, Frank D, Bea F, Katus HA, Frey N.
    Basic Res Cardiol; 2010 Mar 25; 105(2):301-13. PubMed ID: 19629561
    [Abstract] [Full Text] [Related]

  • 20. Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES.
    Gong R, Rifai A, Tolbert EM, Biswas P, Centracchio JN, Dworkin LD.
    J Am Soc Nephrol; 2004 Nov 25; 15(11):2868-81. PubMed ID: 15504940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.